TRIHEXYPHENIDYL Drug Patent Profile
✉ Email this page to a colleague
When do Trihexyphenidyl patents expire, and when can generic versions of Trihexyphenidyl launch?
Trihexyphenidyl is a drug marketed by Chartwell Rx, Pharm Assoc, Pharm Ventures, Hikma, Natco Pharma Ltd, Novitium Pharma, Nylos, Vangard, and Watson Labs. and is included in thirteen NDAs.
The generic ingredient in TRIHEXYPHENIDYL is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trihexyphenidyl
A generic version of TRIHEXYPHENIDYL was approved as trihexyphenidyl hydrochloride by WATSON LABS on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TRIHEXYPHENIDYL?
- What are the global sales for TRIHEXYPHENIDYL?
- What is Average Wholesale Price for TRIHEXYPHENIDYL?
Summary for TRIHEXYPHENIDYL
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 13 |
| Drug Prices: | Drug price information for TRIHEXYPHENIDYL |
| DailyMed Link: | TRIHEXYPHENIDYL at DailyMed |


